OPALINE : A Study Of Morbidity And Mortality At 2 Years
Status:
Completed
Trial end date:
2019-11-18
Target enrollment:
Participant gender:
Summary
A descriptive, prospective (partly retrospective), multisite, observational study conducted
in France in adult patients treated for a well differentiated, unresectable or metastatic,
pancreatic neuroendocrine tumor with disease progression.